Table for the 6 triples with object "The FDA notes that this is a "weak" CYP1A2 inhibitor in vivo in it most recent guidance document. See Table 6, p23" sorted by label

Subject	Predicate
?:evidence_1066	?:content
?:evidence_1237	?:content
?:evidence_1256	?:content
?:evidence_1819	?:content
?:evidence_1836	?:content
?:evidence_1857	?:content